Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-29 @ 3:23 AM
Study NCT ID:
NCT04902560
Status:
COMPLETED
Last Update Posted:
2021-10-19
First Post:
2021-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Response Rate to Ceftriaxone 1g IM in Gonorrhoea : a French Retrospective Monocentric Study
Sponsor:
University Hospital, Montpellier
Organization:
Study Overview
Official Title:
Overall Patient Care in a Montpelier Sexual Health Center (CeGIDD). Response Rate to Ceftriaxone 1g IM in Gonorrhoea : a French Retrospective Monocentric Study
Status:
COMPLETED
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GONOCEF
Brief Summary:
Sexual health centers (CeGIDD, in France) manage the majority of STI in France, especially gonorrhea.
Patients wanting STI screening can consult either they are symptomatic or not.
If they are symptomatic, they can be treated immediately. If they are not symptomatic, they must come back seven days after in order to get their results and to be treated if necessary.
Before any treatment for gonorrhea, subjects should be sampled for bacterial culture in order to perform AMR surveillance.
After every treatment for gonorrhea, subjects should realized a test of cure (TOC) according to current recommandation.
Response rate to ceftriaxone 1g IM for treating gonorrhea has never been evaluated in France while being used widely over the past months.
Compliance to current recommandation at CeGIDD Montpellier has never been evaluated.
This study will assess the response rate to ceftriaxone 1g IM as gonorrhea treatment by realizing a test of cure 14 days after each treatment.
Patients wanting STI screening can consult either they are symptomatic or not.
If they are symptomatic, they can be treated immediately. If they are not symptomatic, they must come back seven days after in order to get their results and to be treated if necessary.
Before any treatment for gonorrhea, subjects should be sampled for bacterial culture in order to perform AMR surveillance.
After every treatment for gonorrhea, subjects should realized a test of cure (TOC) according to current recommandation.
Response rate to ceftriaxone 1g IM for treating gonorrhea has never been evaluated in France while being used widely over the past months.
Compliance to current recommandation at CeGIDD Montpellier has never been evaluated.
This study will assess the response rate to ceftriaxone 1g IM as gonorrhea treatment by realizing a test of cure 14 days after each treatment.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: